ost breast cancer radiation patients qualify for 15 sessions, not 25. NCCN 2026 guidelines and ASTRO's cardiac threshold <2 Gy explained.

Lumpectomy vs mastectomy: for Stage I-II, survival rates are equal. Here are the 5 factors surgeons weigh before deciding.

DCIS breast cancer: 99% survival rate when treated, but grade 3 with comedo necrosis changes the surgical decision. A gynecologic oncologist explains.

Metastatic breast cancer treatment in 2026 depends on receptor status — which can change between your original tumor and the metastatic site.

Inflammatory breast cancer is Stage IIIB at every diagnosis per NCCN 2026 — it invades lymphatic vessels in the breast skin, never forming a lump.

HER2-positive breast cancer entered a new treatment era in 2026 after Enhertu reached 92.4% IDFS in DESTINY-Breast05 patients.

Triple-negative breast cancer: Stage I carries ~91% 5-year survival, but Stage IV drops to 12%. A gynecologic oncologist explains what pCR changes.

Breast cancer mammograms: ACS, USPSTF, and ACR now align on age 40 — but BRCA carriers start a decade earlier. Know your protocol.

Breast cancer risk: BRCA1 mutation raises lifetime risk to 72%. Each daily drink adds 10% more — and a 20% Tyrer-Cuzick score changes your care plan.

Breast cancer types determine which drugs you get. TNBC needs pembrolizumab; HER2+ needs trastuzumab. Know your type before your first appointment.